---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-200715"
form_type: "8-K"
ticker: "DNTH"
cik: "0001690585"
company_name: "Dianthus Therapeutics, Inc. /DE/"
filed_at: "2025-09-11T23:59:59+00:00"
generated_at: "2026-05-17T06:53:19.085923+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Dianthus raises ~$270M in public offering of common stock and pre-funded warrants

## Summary
- Issued 6,487,879 common shares at $33.00/share and 1,112,121 pre-funded warrants at $32.999/share.
- Underwriters exercised in full option for additional 1,140,000 shares.
- Net proceeds expected to be approximately $270 million after discounts and expenses.
- Offering priced Sept 9, 2025; closing expected Sept 11, 2025.
- Pre-funded warrants exercisable at any time; beneficial ownership cap of 4.99%-19.99%.

## SEC filing metadata
- accession: 0001193125-25-200715
- form_type: 8-K
- ticker: DNTH
- cik: 0001690585
- company_name: Dianthus Therapeutics, Inc. /DE/
- filed_at: 2025-09-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690585/000119312525200715/0001193125-25-200715-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690585/000119312525200715/d96557d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-200715
- JSON: https://secwatch.observer/filing/0001193125-25-200715.json
- Plain text: https://secwatch.observer/filing/0001193125-25-200715.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.